US Patent Issued to ABREXA PHARMACEUTICALS on July 15 for "Compounds for prevention and treatment of obesity and related disorders" (California Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,596, issued on July 15, was assigned to ABREXA PHARMACEUTICALS INC. (San Diego).

"Compounds for prevention and treatment of obesity and related disorders" was invented by Jesus E. Villafranca (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Presented herein, in certain aspects, are methods of treating or preventing obesity, assisting or inducing weight loss, suppressing apatite, or inhibiting weight gain in a subject by administering a compound of the invention to a subject."

The patent was filed on March 2, 2020, under Application No. 17/435,678.

*For further information, including images, charts and tables, please visit: http://patft.us...